Malik AT, Retchin S, Phillips FM, et al. - In this retrospective review of 2008-2015Q3 Humana Administrative Claims database, experts learned about trends, costs and clinical influence correlated the utilization of anti-osteoporotic medication and screening with the one year after occurrences of sentinel/primary osteoporotic vertebral compression fractures (VCFs). A total of 6,464 primary osteoporotic VCFs were pooled from the database. In summary, the proportion of individuals starting anti-osteoporotic medication within a year following a VCF continues as low. Moreover, a decreasing trend of anti-osteoporotic medication prescription was observed over time. In order to decrease the burden of future fragility fractures, providers who care for persons with sentinel VCFs are needed to be more persistent in their efforts to detect and treat the underlying osteoporosis.